Medicare · National
Medicare
Medicare publishes coverage policies for 4 of the 4 sleep apnea treatments we track. Each is linked to its source document below.
By treatment
CPAP and PAP therapy
Policy publishedPolicy number — NCD 240.4
Effective — 2008-03-13
Before treatment starts
Initial qualification
- In-person clinical evaluation by the treating practitioner before the sleep test.
- Sleep testing must be ordered by the treating practitioner and meet Medicare testing rules.
- AHI/RDI must meet Medicare thresholds, including the required event count and qualifying symptoms when applicable.
- The supplier must instruct the beneficiary or caregiver on proper PAP use and care.
After treatment starts
Continued coverage
- Clinical re-evaluation between days 31 and 91 must document that PAP symptoms improved.
- Objective use must show at least 4 hours/night on 70% of nights in one consecutive 30-day period during the first 3 months.
- A late re-evaluation can restart coverage from that visit once benefit and adherence are documented.
- After a failed initial 12-week trial, requalification requires in-person re-evaluation and a repeat facility-based Type 1 sleep study.
Oral appliance therapy
Policy publishedHypoglossal nerve stimulation
Policy publishedPolicy number — L38276
Effective — 2026-05-14
Published utilization-management detail
- Documented CPAP failure despite optimization or documented CPAP intolerance
Tirzepatide (Zepbound) for OSA
Policy publishedLast verified 2026-08-15. We record structured facts and link the source; we do not reproduce policy text. The document itself governs.
If you're denied
Medicare publishes its own appeal instructions. Start there, and note the deadline on your denial letter.
Your specific plan may differ from Medicare's general policy, particularly if your coverage is through an employer. Policies are revised without notice. Nothing here is a guarantee of coverage or a substitute for confirming with your plan.